1. PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4
   Xiaohong Fei et al, 2023, International Immunopharmacology CrossRef
2. Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach
   Debomita Bhattacharya et al, 2023, European Journal of Medicinal Chemistry CrossRef
3. Overview of the development of protein arginine methyltransferase modulators: Achievements and future directions
   Chao Tong et al, 2024, European Journal of Medicinal Chemistry CrossRef
4. Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
   Yan Zhang et al, 2024, Diabetes & Metabolism Journal CrossRef
5. PRMT1 in human neoplasm: cancer biology and potential therapeutic target
   Shiquan Shen et al, 2024, Cell Communication and Signaling CrossRef
6. Role of protein arginine methyltransferase 1 in obesity‐related metabolic disorders: Research progress and implications
   Xiaolei Xuan et al, 2024, Diabetes, Obesity and Metabolism CrossRef
7. Blood DNA methylation signature of diet quality and association with cardiometabolic traits
   Jorge Domínguez-Barragán et al, 2024, European Journal of Preventive Cardiology CrossRef